Status:
UNKNOWN
Post-COVID-19 Outpatient Care and Biomarkers
Lead Sponsor:
Medical University of Vienna
Conditions:
Post Viral Fatigue
Viral Myocarditis
Eligibility:
All Genders
18-90 years
Brief Summary
The aims of this case-control, non-randomized study including patients with post-COVID-19 persisting symptoms are 1) to establish the large blood biobank, 2) to examine levels of circulating inflammat...
Detailed Description
Currently, several studies are ongoing to investigate different treatment modalities of post-COVID-19 symptoms, but there is a complete lack of investigations on biomarkers predicting type, duration o...
Eligibility Criteria
Inclusion
- For post-COVID patient group:
- Age≥18to90years
- Proven infection by SARS-CoV2, at least 3 weeks after recovery from the infection
- Signed informed consent For HFrEF patient group:
- For vaccinated healthy volunteer control group:
- Full vaccination against SARS-CoV2 at least 3 weeks before inclusion in the study
- Signed informed consent
Exclusion
- non-willingness to participate or withdrawal of informed consent
- Clinically confirmed HFrEF (EF \<40%)
- participation in any SARS-CoV-2 medical treatment trial
- pregnancy
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05398952
Start Date
April 1 2021
End Date
December 31 2025
Last Update
June 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, Medical University of Vienna
Vienna, Austria, 1090